
    
      The patient is prospectively included. The referring hematologist will inform the patient
      about participation in the cohort, give him the information note and obtain his non-objection
      agreement to the use of his data for research purposes.

      The data will be collected from the medical file of each patient as part of his usual annual
      follow-up.
    
  